Document Detail


Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
MedLine Citation:
PMID:  17600478     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our recent findings have shown that the reverse transcriptase (RT) inhibitors, nevirapine and efavirenz, used for 10 years in human immunodeficiency virus (HIV) disease, act as cytostatic and differentiating agents by modulating gene expression in several human tumor cell models. In dedifferentiated thyroid cancer, they reestablish thyroid-stimulating hormone (TSH) signaling, Na/I symporter (NIS), thyroglobulin peroxidase (TPO) expression, and even radioiodine uptake (RIU). In this paper, we describe the case of a 76-year-old woman who was affected by thyroid papillary carcinoma and who underwent a total thyroidectomy and a debulking of the right laterocervical region for lymph-node metastases, vessel infiltration, and neoplastic thrombosis of the internal jugular vein, followed by 3 radioiodine treatments. At restaging, a computed tomography scan revealed that distant metastases were mostly not taking up the radioiodine at the 131I whole-body scan (WBS). An analysis of tumor cells obtained by fine-needle aspiration biopsy of a right laterocervical lymph-node revealed cell anisokaryosis, nuclear pleomorphism, and scanty colloid, as well as the undetectable expression of thyroglobulin and NIS proteins. After starting a nevirapine treatment (NT), higher thyroglobulin levels were observed and some metastases exhibited a significant increase in radioiodine uptake, which led us to again treat the patient with 131I. Five (5) months later, the 131I-WBS revealed the disappearance of RIU in some metastases and its significant reduction in other lesions, with a parallel drop in serum thyroglobulin. No new metastatic lesion was revealed by rh-TSH-stimulated 131IWBS and 18F-flourodeoxyglucose positron emission tomography scan. Cells obtained from the right laterocervical lymph-node 2 months after NT exhibited a reduced nuclear pleomorphism, an increase in colloid production, and a significant upregulation of thyroglobulin and NIS protein expression. This first in vivo molecular and morphologic evidence of cell differentiation in human cancer and low toxicity of nevirapine strongly encourage its use in dedifferentiated thyroid cancer treatment.
Authors:
Sergio Modoni; Matteo Landriscina; Annarita Fabiano; Alberto Fersini; Nicoletta Urbano; Antonio Ambrosi; Mauro Cignarelli
Related Documents :
4060258 - Amphicrine--composite calcitonin and mucin-producing--carcinoma of the thyroid.
15043468 - Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar...
24270418 - Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresis...
11048798 - Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid...
15342668 - Diagnosis of peripheral nerve sheath tumors around the pelvis.
18607508 - Gemcitabine-mediated radiosensitization of human soft tissue sarcoma.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cancer biotherapy & radiopharmaceuticals     Volume:  22     ISSN:  1084-9785     ISO Abbreviation:  Cancer Biother. Radiopharm.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-06-29     Completed Date:  2007-09-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9605408     Medline TA:  Cancer Biother Radiopharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  289-95     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (PZ), Italy. sergiomodoni@tin.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biopsy, Fine-Needle
Cell Differentiation / drug effects*
Cell Shape
Female
Humans
Iodine Radioisotopes / pharmacokinetics*
Lymphatic Metastasis / pathology
Nevirapine / pharmacology*,  therapeutic use
Positron-Emission Tomography
Reverse Transcriptase Inhibitors / pharmacology*,  therapeutic use
Thyroid Neoplasms / drug therapy,  pathology*,  radiotherapy*
Tomography Scanners, X-Ray Computed
Whole-Body Counting
Chemical
Reg. No./Substance:
0/Iodine Radioisotopes; 0/Reverse Transcriptase Inhibitors; 129618-40-2/Nevirapine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Semiautomated thoracic and abdominal computed tomography segmentation using the belief functions the...
Next Document:  Radiosynoviorthesis of knees by means of 166Ho-holmium-boro-macroaggregates.